CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients

CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients

Background: Osimertinib has shown greater efficacy than standard epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and fewer grade 3 or higher adverse drug reactions (ADRs) in patients with advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (...

Full description

Saved in:
Bibliographic Details
Main Authors: Teerapat Majam (Author), Chonlaphat Sukasem (Author), Thanyanan Reungwetwattana (Author), Phichai Chansriwong (Author), Chalirmporn Atasilp (Author), Narumol Trachu (Author), Thanaporn Thamrongjirapat (Author), Rattanaporn Sukprasong (Author), Jennis Meanwatthana (Author)
Format: Book
Published: Frontiers Media S.A., 2023-11-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items